Literature DB >> 7909044

Radiolabelled meta-iodobenzylguanidine in assessment of autonomic dysfunction.

Y Ando, K Obayashi, Y Tanaka, T Tsuji, M Uchino, M Takahashi, M Ando.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7909044     DOI： 10.1016/s0140-6736(94)90113-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis).

Authors:  Alejandra Gonzalez-Duarte
Journal:  Clin Auton Res       Date:  2018-03-06       Impact factor: 4.435

Review 2.  The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes.

Authors:  S Braune
Journal:  Clin Auton Res       Date:  2001-12       Impact factor: 4.435

3.  Elderly patients with suspected Charcot-Marie-Tooth disease should be tested for the TTR gene for effective treatments.

Authors:  Takaki Taniguchi; Masahiro Ando; Yuji Okamoto; Akiko Yoshimura; Yujiro Higuchi; Akihiro Hashiguchi; Nozomu Matsuda; Mamoru Yamamoto; Eisuke Dohi; Makoto Takahashi; Masanao Yoshino; Taichi Nomura; Masaaki Matsushima; Ichiro Yabe; Yui Sanpei; Hiroyuki Ishiura; Jun Mitsui; Masanori Nakagawa; Shoji Tsuji; Hiroshi Takashima
Journal:  J Hum Genet       Date:  2022-01-14       Impact factor: 3.172

4.  A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies.

Authors:  M Yoshita; J Taki; M Yamada
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

5.  Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.

Authors:  Haruki Koike; Tomohiko Nakamura; Atsushi Hashizume; Ryoji Nishi; Shohei Ikeda; Yuichi Kawagashira; Masahiro Iijima; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2017-10-05       Impact factor: 4.849

Review 6.  Multidisciplinary Approaches for Transthyretin Amyloidosis.

Authors:  Haruki Koike; Takahiro Okumura; Toyoaki Murohara; Masahisa Katsuno
Journal:  Cardiol Ther       Date:  2021-06-04

7.  Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S).

Authors:  Taku Nakase; Taro Yamashita; Yoshimasa Matsuo; Toshiya Nomura; Keiko Sasada; Teruaki Masuda; Yohei Misumi; Kotaro Takamatsu; Seitaro Oda; Yutaro Furukawa; Konen Obayashi; Hirotaka Matsui; Yukio Ando; Mitsuharu Ueda
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271

8.  Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.

Authors:  Alejandra González-Duarte; John L Berk; Dianna Quan; Michelle L Mauermann; Hartmut H Schmidt; Michael Polydefkis; Márcia Waddington-Cruz; Mitsuharu Ueda; Isabel M Conceição; Arnt V Kristen; Teresa Coelho; Cécile A Cauquil; Céline Tard; Madeline Merkel; Emre Aldinc; Jihong Chen; Marianne T Sweetser; Jing Jing Wang; David Adams
Journal:  J Neurol       Date:  2019-11-14       Impact factor: 4.849
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.